Opexa Therapeutics CEO Chris Schelling's 2022 pay jumps 51% to $834K
Opexa Therapeutics reports 2022 executive compensation
By ExecPay News
Published: April 14, 2023
Opexa Therapeutics reported fiscal year 2022 executive compensation information on April 14, 2023.
In 2022, three executives at Opexa Therapeutics received on average a compensation package of $743K, a 28% increase compared to previous year.
Average pay of disclosed executives at Opexa Therapeutics
Chris Schelling, Chief Executive Officer, received $834K in total, which increased by 51% compared to 2021. 60% of Schelling's compensation, or $500K, was in salary. Schelling also received $240K in bonus and $94K in option awards.
Adrian Quartel, Chief Medical Officer, received a compensation package of $801K. 54% of the compensation package, or $436K, was in option awards.
Harry Palmin, Chief Financial Officer, earned $593K in 2022, a 6% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 14, 2023.